Hourly refreshThu, Oct 29, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

3,756 press releases in English indexed under healthcare.

Clear all filters
Keywords, dates and language
Sources
up to 10
Newswires (50)
Company newsrooms (91)
Companies
Releases linked to any of up to 10 companies
AllFinanceCryptoAISaaSHealthcareReal estateEnergyRetailAutomotiveGamingMediaEducation
+ 33 more topics
DownloadExcelTXT
SaaS · Healthcare

Computer System Validation (CSV) Implementation Boot Camp: Practical Validation of GxP Computerised Systems (Aug 19th - Aug 21st, 2026)

As life sciences, pharmaceutical, biotech, and medical device organizations accelerate digital transformation highlighted by the shift toward FDA Computer Software Assurance (CSA) draft guidance, GAMP® 5 (Second Edition) risk-based validation, and cloud/SaaS deployments ensuring 21 CFR Part 11 and EU Annex 11 regulatory compliance remains paramount. This practical training course equips QA/QC professionals, IT system owners, and regulatory auditors with actionable methodologies for modernizing the System Development Life Cycle (SDLC), conducting critical-thinking risk assessments, writing IQ/OQ/PQ test protocols, maintaining data integrity, and establishing audit-ready documentation across the full system lifecycle. As life sciences, pharmaceutical, biotech, and medical device organizations accelerate digital transformation highlighted by the shift toward FDA Computer Software Assurance (CSA) draft guidance, GAMP® 5 (Second Edition) risk-based validation, and cloud/SaaS deployments ensuring 21 CFR Part 11 and EU Annex 11 regulatory compliance remains paramount. This practical training course equips QA/QC professionals, IT system owners, and regulatory auditors with actionable methodologies for modernizing the System Development Life Cycle (SDLC), conducting critical-thinking risk assessments, writing IQ/OQ/PQ test protocols, maintaining data integrity, and establishing audit-ready documentation across the full system lifecycle.

Aug 17 · 09:04GlobeNewswire
AI · Healthcare

FDA Inspection Readiness in the AI Era 2026 (Aug 20th - Aug 21st, 2026)

Opportunities include AI-enabled continuous inspection readiness, stronger GMP and data-integrity compliance, more effective CAPA and quality-culture systems, and training to help pharma and biotech firms meet evolving FDA expectations. Opportunities include AI-enabled continuous inspection readiness, stronger GMP and data-integrity compliance, more effective CAPA and quality-culture systems, and training to help pharma and biotech firms meet evolving FDA expectations.

Aug 17 · 08:59GlobeNewswire
Healthcare · Education

2-Day Virtual Seminar: Practical ICH Q10 Pharmaceutical Quality System (PQS) Implementation for FDA Compliance & Inspection Readiness (August 26–27, 2026)

Designed to help pharmaceutical and biotechnology organizations navigate evolving global regulatory expectations from the FDA, EMA, and MHRA, this intensive 2-day virtual seminar delivers practical strategies for designing, implementing, maintaining, and continually improving a robust Pharmaceutical Quality System (PQS). The course covers essential PQS frameworks based on ICH Q10 and ICH Q9(R1) Quality Risk Management, focusing on key operational components including Corrective and Preventive Action (CAPA) systems, change control, supplier quality management, process performance and product quality monitoring, and audit readiness to prevent compliance gaps. Designed to help pharmaceutical and biotechnology organizations navigate evolving global regulatory expectations from the FDA, EMA, and MHRA, this intensive 2-day virtual seminar delivers practical strategies for designing, implementing, maintaining, and continually improving a robust Pharmaceutical Quality System (PQS). The course covers essential PQS frameworks based on ICH Q10 and ICH Q9(R1) Quality Risk Management, focusing on key operational components including Corrective and Preventive Action (CAPA) systems, change control, supplier quality management, process performance and product quality monitoring, and audit readiness to prevent compliance gaps.

Aug 17 · 08:58GlobeNewswire
Healthcare

/C O R R E C T I O N -- The Galien Foundation/

In the news release, The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup", issued 13-Aug-2026 by The Galien Foundation over PR Newswire, we are advised by the...

Aug 17 · 08:13PR Newswire
Healthcare

Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc

FORM 8.5 (EPT/RI)

Aug 17 · 08:11GlobeNewswire
Healthcare · Biotech & pharma

Zelluna ASA: Notice of EGM – experienced international biotech executive proposed for election to the Board and Board member steps down

Oslo, 17 August 2026: The Board of Directors of Zelluna ASA (the “Company”) hereby calls for an Extraordinary General Meeting to be held on 9 September 2026 at 13:00 CEST, regarding election of a new member of the Company’s Board of Directors (the “Board”).

Aug 17 · 05:45GlobeNewswire
Finance · Healthcare

Endeavour Silver Reports an Illegal Blockade and Suspension of Operations at its Terronera Mine

VANCOUVER, British Columbia, Aug. 16, 2026 -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports that operations at its Terronera mine in Jalisco, Mexico have been temporarily suspended since August 12th as the result of an illegal blockade by members of the nearby Ejido community regarding their concerns over road maintenance, assistance with medical services and communications, control and access to water supply and increased financial assistance. To date, the blockade has remained peaceful, orderly and respectful.

Aug 17 · 01:00GlobeNewswire
Finance · Healthcare

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

NEW YORK, Aug. 16, 2026 -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in the MSB-DR004 pivotal randomized controlled Phase 3 trial of rexlemestrocel-L for chronic low back pain (CLBP) associated with the inflammatory condition of degenerative disc disease. The major milestone was achieved with 350 patients randomized and treated with either an intra-discal injection of rexlemestrocel-L or sham injection. Total patient numbers treated increased from 300 to 350 after strong demand from trial investigators to have their patients enrolled in the innovative program.

Aug 17 · 00:35GlobeNewswire
Healthcare · Biotech & pharma

AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma

ROCKVILLE, Md. and SHANGHAI, Aug. 16, 2026 -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced that...

Aug 17 · 00:00PR Newswire
Healthcare · Cybersecurity

BAYLOR GENETICS DATA BREACH ALERT: Edelson Lechtzin LLP Investigates Exposure of Patient and Employee Personal Information

National class action firm offering free, confidential case evaluations to individuals affected by the Baylor Genetics cybersecurity incident HOUSTON, Aug. 16, 2026 -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from...

Aug 16 · 21:40PR Newswire
Healthcare · Cybersecurity

LONE STAR COMMUNITY HEALTH DATA BREACH ALERT: Edelson Lechtzin LLP Investigates Exposure of 250,130 Patients' Personal and Medical Information

National class action firm offering free, confidential case evaluations to Texas patients affected by the Lone Star Community Health Center / Aesto Health data breach CONROE, Texas, Aug. 16, 2026 -- Edelson Lechtzin LLP, a national class action law firm, is investigating data...

Aug 16 · 19:45PR Newswire
Healthcare

In HelloNation, Family Dental Care Experts Dr. Joseph T. Sumrall and Dr. Gran Sumrall of Warner Robins, GA, Explain Why Cosmetic Dental Changes Focus on Looking Natural

The article explains how modern cosmetic dentistry uses subtle changes, advanced materials, and personalized planning to create results that complement a patient's natural smile. WARNER ROBINS, Ga., Aug. 16, 2026 -- What makes today's cosmetic dentistry look more natural than...

Aug 16 · 14:19PR Newswire